These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12118689)

  • 1. Hematological toxicity and therapeutic efficacy of lomustine in 20 tumor-bearing cats: critical assessment of a practical dosing regimen.
    Fan TM; Kitchell BE; Dhaliwal RS; Jones PD; Hintermeister JG; Paria BC
    J Am Anim Hosp Assoc; 2002; 38(4):357-63. PubMed ID: 12118689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005).
    Rassnick KM; Williams LE; Kristal O; Al-Sarraf R; Baez JL; Zwahlen CH; Dank G
    J Am Vet Med Assoc; 2008 Apr; 232(8):1200-5. PubMed ID: 18412534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCNU (lomustine) toxicity in dogs: a retrospective study (2002-07).
    Heading KL; Brockley LK; Bennett PF
    Aust Vet J; 2011 Apr; 89(4):109-16. PubMed ID: 21418164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability of lomustine in combination with cyclophosphamide in dogs with lymphoma.
    Rassnick KM; Bailey DB; Malone EK; Flory AB; Kiselow MA; Intile JL
    J Am Anim Hosp Assoc; 2014; 50(3):167-73. PubMed ID: 24659727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I evaluation of CCNU (lomustine) in tumor-bearing cats.
    Rassnick KM; Gieger TL; Williams LE; Ruslander DM; Northrup NC; Kristal O; Myers NC; Moore AS
    J Vet Intern Med; 2001; 15(3):196-9. PubMed ID: 11380027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability of metronomic administration of lomustine in dogs with cancer.
    Tripp CD; Fidel J; Anderson CL; Patrick M; Pratt C; Sellon R; Bryan JN
    J Vet Intern Med; 2011; 25(2):278-84. PubMed ID: 21314727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lomustine (CCNU) for the treatment of resistant lymphoma in dogs.
    Moore AS; London CA; Wood CA; Williams LE; Cotter SM; L'Heureux DA; Frimberger AE
    J Vet Intern Med; 1999; 13(5):395-8. PubMed ID: 10499719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective evaluation of lomustine (CeeNU) in 32 treatment naïve cats with intermediate to large cell gastrointestinal lymphoma (2006-2013).
    Rau SE; Burgess KE
    Vet Comp Oncol; 2017 Sep; 15(3):1019-1028. PubMed ID: 27277825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary fibrosis after high cumulative dose nitrosourea chemotherapy in a cat.
    Skorupski KA; Durham AC; Duda L; Sørenmo KU
    Vet Comp Oncol; 2008 Jun; 6(2):120-5. PubMed ID: 19178671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I clinical evaluation of carboplatin in tumor-bearing cats: a Veterinary Cooperative Oncology Group study.
    Kisseberth WC; Vail DM; Yaissle J; Jeglum KA; Couto CG; Ward H; Khanna C; Obradovich JE
    J Vet Intern Med; 2008; 22(1):83-8. PubMed ID: 18289293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of lomustine as a rescue agent for cats with resistant lymphoma.
    Dutelle AL; Bulman-Fleming JC; Lewis CA; Rosenberg MP
    J Feline Med Surg; 2012 Oct; 14(10):694-700. PubMed ID: 22577051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosage escalation of intravenous cyclophosphamide in cats with cancer.
    Moore AS; Frimberger AE; Chan CM
    Vet J; 2018 Dec; 242():39-43. PubMed ID: 30503542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overdose of lomustine: report of two cases.
    Büyükçelik A; Akbulut H; Yalçin B; Ozdemir F; Içli F
    Tumori; 2004; 90(6):628-9. PubMed ID: 15762370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005).
    Sauerbrey ML; Mullins MN; Bannink EO; Van Dorp TE; Kaneene JB; Obradovich JE
    J Am Vet Med Assoc; 2007 Jun; 230(12):1866-9. PubMed ID: 17571992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of lomustine to treat cutaneous nonepitheliotropic lymphoma in a cat.
    Komori S; Nakamura S; Takahashi K; Tagawa M
    J Am Vet Med Assoc; 2005 Jan; 226(2):237-9, 219. PubMed ID: 15706974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II clinical evaluation of lomustine chemotherapy for feline vaccine-associated sarcoma.
    Saba CF; Vail DM; Thamm DH
    Vet Comp Oncol; 2012 Dec; 10(4):283-91. PubMed ID: 22236148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low apparent risk of CCNU (lomustine)-associated clinical hepatotoxicity in cats.
    Musser ML; Quinn HT; Chretin JD
    J Feline Med Surg; 2012 Dec; 14(12):871-5. PubMed ID: 22772480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of lithium carbonate to prevent lomustine-induced myelosuppression in dogs: a pilot study.
    Abrams-Ogg AC
    Can J Vet Res; 2011 Jan; 75(1):73-6. PubMed ID: 21461200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective evaluation of nimustine use in the treatment of feline lymphoma.
    Sakai K; Hatoya S; Furuya M; Nabetani T; Kanegi R; Shimamura S; Tani H; Shimada T
    Vet Med Sci; 2022 Jan; 8(1):3-8. PubMed ID: 34599792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I trial of weekly lomustine in patients with advanced cancer.
    Koller CA; Gorski CC; Benjamin RS; Legha SS; Papadopoulos NE; Plager C
    Cancer; 1994 Jan; 73(1):236-9. PubMed ID: 8275432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.